(Q50554929)

15 March 2018

reason for preferred rank

title

MMP-2 Mediates Angiotensin II–Induced Hypertension Under the Transcriptional Control of MMP-7 and TACE (English)

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

27 August 2024

MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21079048

enzymologic gene expression regulation

27 August 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21079048

27 August 2024

author name string

Jeffrey Odenbach

1

1 reference

15 March 2018

Xiang Wang

2

1 reference

15 March 2018

Stephan Cooper

3

1 reference

15 March 2018

Fung Lan Chow

4

1 reference

15 March 2018

Tatsujiro Oka

5

1 reference

15 March 2018

Gary Lopaschuk

6

1 reference

15 March 2018

Zamaneh Kassiri

7

1 reference

15 March 2018

Carlos Fernandez-Patron

8

1 reference

15 March 2018

language of work or name

English

0 references

publication date

15 November 2010

1 reference

15 March 2018

full work available at URL

https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.110.159525

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21079048

http://intl-hyper.ahajournals.org/cgi/content/abstract/57/1/123

27 August 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21079048

https://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.110.159525

27 August 2024

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

27 August 2024

1 reference

15 March 2018

volume

57

1 reference

15 March 2018

issue

1

1 reference

15 March 2018

page(s)

123-130

1 reference

15 March 2018

Molecular mechanisms of human hypertension

cites work

1

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Myocardial collagen matrix remodelling in arterial hypertension

27 August 2024

2

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Mechanisms of cardiac fibrosis in hypertension

27 August 2024

3

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

ECM remodeling in hypertensive heart disease

27 August 2024

5

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

27 August 2024

6

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

27 August 2024

7

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway

27 August 2024

8

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach

27 August 2024

9

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II

27 August 2024

10

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor

27 August 2024

11

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction

27 August 2024

12

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator

27 August 2024

13

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.

27 August 2024

14

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis

27 August 2024

15

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction

27 August 2024

16

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.

27 August 2024

17

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat.

27 August 2024

18

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats

27 August 2024

19

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Vascular responses to alpha1-adrenergic receptors in small rat mesenteric arteries depend on mitochondrial reactive oxygen species

27 August 2024

20

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense.

27 August 2024

21

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

A factor that initiates myocardial hypertrophy in hypertension

27 August 2024

22

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in mice

27 August 2024

23

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload

27 August 2024

24

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both alpha 1- and beta-adrenoceptors

27 August 2024

26

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Angiotensin II induces cardiomyocyte hypertrophy probably through histone deacetylases

27 August 2024

27

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

The athlete's heart syndrome: a new perspective

27 August 2024

28

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

27 August 2024

29

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney

27 August 2024

30

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Cross talk between angiotensin II and alpha 1 adrenergic receptors in rabbit aorta: role of endothelium

27 August 2024

31

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Human progelatinase A can be activated by matrilysin

27 August 2024

33

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling

27 August 2024

36

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

p53 Mediates epidermal growth factor (EGF) induction of MMP-2 transcription and trophoblast invasion

27 August 2024

37

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity

27 August 2024

38

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats

27 August 2024

39

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

27 August 2024

40

1 reference

https://api.crossref.org/works/10.1161/HYPERTENSIONAHA.110.159525

27 August 2024

Identifiers

1 reference

15 March 2018

1 reference

15 March 2018